ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter …

One primary mechanism for bacteria developing resistance is frequent exposure to
antibiotics. Nanoantibiotics (nAbts) is one of the strategies being explored to counteract the …

Antibiotic resistance is a global health issue and a potential risk for society. Antibiotics
administered through conventional formulations are devoid of targeting effect and often …

Introduction: In recent years, the wider use of nanotechnology has attracted greater attention
from scientists in multi-disciplinary fields. Nanotechnological research has come a long way …

The accelerated appearance of drug-resistant bacteria poses an ever-growing threat to
modern medicine's capacity to fight infectious diseases. Gram-positive species such as …

Hybrid nanoparticles (NPs) are emerging as superior alternatives to conventional
nanocarriers for enhancing the delivery of antibiotics and improving their targeting at the …

Lipid-polymer hybrid nanoparticles (LPHNP) are delivery systems for controlled drug
delivery at tumor sites. The superior biocompatible properties of lipids and structural …

The spread of antimicrobial resistance in Gram-positive pathogens represents a threat to
human health. To counteract the current lack of novel antibiotics, alternative antibacterial …

MRSA infections are a major global healthcare problem associated with high morbidity and
mortality. The application of novel materials in antibiotic delivery has efficiently contributed to …

The development of novel materials is necessary for adequate delivery of drugs to combat
the Methicillin-resistant Staphylococcus aureus (MRSA) burden due to the limitations of …